AbbVie
ABBV
#25
Rank
S$667.58 B
Marketcap
S$377.67
Share price
-0.59%
Change (1 day)
23.88%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2026 (TTM): S$7.52

According to AbbVie's latest financial reports the company's current EPS (TTM) is S$7.55. In 2025 the company made an earnings per share (EPS) of S$3.05 a decrease over its 2024 EPS that were of S$3.12.

EPS history for AbbVie from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$7.52146.29%
2025S$3.05-2.26%
2024S$3.12-11.86%
2023S$3.54-58.95%
2022S$8.632.49%
2021S$8.42121.58%
2020S$3.80-44.7%
2019S$6.8845.84%
2018S$4.719.72%
2017S$4.30-9.54%
2016S$4.7516.28%
2015S$4.08184.1%
2014S$1.44-57.15%
2013S$3.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$0.92-87.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.84 427.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$22.42 197.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$3.04-59.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S-$4.00-152.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.83-22.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$9.18 21.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$3.71-50.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$8.99 19.11%๐Ÿ‡บ๐Ÿ‡ธ USA